Patents by Inventor Kaare M. Gautvik

Kaare M. Gautvik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6962796
    Abstract: The invention provides recombinant plasmids containing in DNA sequences coding for human preproparathyroid hormone. The invention further provides microorganisms, for example E. coli, transformed by these plasmids. The invention also provides a plasmid for insertion into yeast and a transformed yeast in which the plasmid contains DNA coding for parathyroid hormone. Parathyroid hormone is then secreted by the transformed yeast. Further the invention provides alternate polypeptides having parathyroid hormone activity, including PTH analogs, fragments and extensions, and provides alternate leader sequences and secretion signal sequences which can be used in the present invention. Finally, there are provided methods for purification of the secreted PTH hormone and/or derivatives.
    Type: Grant
    Filed: September 25, 2000
    Date of Patent: November 8, 2005
    Assignee: NPS Allelix Corp.
    Inventors: Kaare M. Gautvik, Peter Alestrom, Tordis Beate Oyen, Odd Stokke Gabrielsen
  • Publication number: 20040005668
    Abstract: The invention provides recombinant plasmids containing in DNA sequences coding for human preproparathyroid hormone. The invention further provides microorganisms, for example E. coli, transformed by these plasmids. The invention also provides a plasmid for insertion into yeast and a transformed yeast in which the plasmid contains DNA coding for parathyroid hormone. Parathyroid hormone is then secreted by the transformed yeast. Further the invention provides alternate polypeptides having parathyroid hormone activity, including PTH analogs, fragments and extensions, and provides alternate leader sequences and secretion signal sequences which can be used in the present invention. Finally, there are provided methods for purification of the secreted PTH hormone and/or derivatives.
    Type: Application
    Filed: February 6, 2003
    Publication date: January 8, 2004
    Applicant: NPS Allelix Corp.
    Inventors: Kaare M. Gautvik, Peter Alestrom, Tordis Beate Oyen, Odd Stokke Gabrielsen
  • Publication number: 20030228665
    Abstract: The invention provides recombinant plasmids containing in DNA sequences coding for human preproparathyroid hormone. The invention further provides microorganisms, for example E. coli, transformed by these plasmids. The invention also provides a plasmid for insertion into yeast and a transformed yeast in which the plasmid contains DNA coding for parathyroid hormone. Parathyroid hormone is then secreted by the transformed yeast. Further the invention provides alternate polypeptides having parathyroid hormone activity, including PTH analogs, fragments and extensions, and provides alternate leader sequences and secretion signal sequences which can be used in the present invention. Finally, there are provided methods for purification of the secreted PTH hormone and/or derivatives.
    Type: Application
    Filed: May 14, 2003
    Publication date: December 11, 2003
    Applicant: Allelix BioPharmaceuticals, Inc.
    Inventors: Kaare M. Gautvik, Peter Alestrom, Tordis Beate Oyen, Odd Stokke Gabrielsen
  • Patent number: 6635479
    Abstract: Disclosed are hypocretin polynucleotides and hypocretin polypeplides, as well as antibodies, oligonucleotides, diagnostic kits and methods, and therapeutic compositions and methods. Hypocretin, one of several novel liypothalamic-specific polypeptides identified isolated and sequenced, is localized to regions of the hypothalamus involved in appetite and feeding behavior. Hypocretin polypeptides are biologically active, producing electrical changes in neurons, lowering body temperature and reducing food intake.
    Type: Grant
    Filed: February 2, 1999
    Date of Patent: October 21, 2003
    Assignee: The Scripps Research Institute
    Inventors: J. Gregor Sutcliffe, Kaare M. Gautvik, Luis De Lecea, Floyd E. Bloom, Patria E. Danielson, Vigdis T. Gautvik, Thomas S. Kilduff, Pamela E. Foye
  • Publication number: 20030176666
    Abstract: Peptides and polypeptides found in the hypothalamus region of the mammalian brain are described, particularly hypocretin polypeptides and their uses. Hypocretin polypeptides are biologically active and produce electrical changes in neurons, lower body temperature, and reduce food intake.
    Type: Application
    Filed: December 12, 2000
    Publication date: September 18, 2003
    Applicant: The Scripps Research Institute
    Inventors: J. Gregor Sutcliffe, Kaare M. Gautvik, Luis De Lecea, Floyd E. Bloom, Patria E. Danielson, Vigdis T. Gautvik, Thomas S. Kilduff, Pamela E. Foye
  • Patent number: 6146852
    Abstract: The invention provides recombinant plasmids containing in DNA sequences coding for human preproparathyroid hormone. The invention further provides microorganisms, for example E. coli, transformed by these plasmids. The invention also provides a plasmid for insertion into yeast and a transformed yeast in which the plasmid contains DNA coding for parathyroid hormone. Parathyroid hormone is then secreted by the transformed yeast. Further the invention provides alternate polypeptides having parathyroid hormone activity, including PTH analogs, fragments and extensions, and provides alternate leader sequences and secretion signal sequences which can be used in the present invention. Finally, there are provided methods for purification of the secreted PTH hormone and/or derivatives.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: November 14, 2000
    Assignee: NPS Allelix Corp.
    Inventors: Kaare M. Gautvik, Peter Alestrom, Tordis Beate Oyen, Odd Stokke Gabrielsen
  • Patent number: 5420242
    Abstract: The invention provides recombinant plasmids containing in DNA sequences coding for human preproparathyroid hormone. The invention further provides microorganisms, for example E. coli, transformed by these plasmids. The invention also provides a plasmid for insertion into yeast and a transformed yeast in which the plasmid contains DNA coding for parathyroid hormone. Parathyroid hormone is then secreted by the transformed yeast. Further the invention provides alternate polypeptides having parathyroid hormone activity, including PTH analogs, fragments and extensions, and provides alternate leader sequences and secretion signal sequences which can be used in the present invention. Finally, there are provided methods for purification of the secreted PTH hormone and/or derivatives.
    Type: Grant
    Filed: July 2, 1993
    Date of Patent: May 30, 1995
    Assignees: Kaare M. Gautvik, Peter Alestrom
    Inventors: Kaare M. Gautvik, Peter Alestrom, Tordis B. Oyen
  • Patent number: 5010010
    Abstract: The invention provides recombinant plasmids containing in DNA sequences coding for human preproparathyroid hormone. The invention further provides microorganisms, for example E. coli, transformed by these plasmids. Finally, the invention also provides a plasmid for insertion into yeast and a transformed yeast in which the plasmid contains DNA coding for parathyroid hormone. Parathyroid hormone is then secreted by the transformed yeast.
    Type: Grant
    Filed: August 14, 1989
    Date of Patent: April 23, 1991
    Assignee: Selmer-Sande, A.S.
    Inventors: Kaare M. Gautvik, Peter Alestrom, Tordis B. Oven, Odd S. Gabrielsen